Search Results
Update on bb2121 CAR T-cell product for MM from EHA 2018
Anti-BCMA CAR T-cells for MM: durable clinical responses with ide-cel (formerly bb2121)
CAR T-cells for multiple myeloma: update & what's in store for ASH 2018
Results from CAR T-cell bb2121 first-in-human trial for R/R MM
Jesus Berdeja | EHA 2018 | Summary of the CRB-401 phase I bb2121 CAR T-cell study
Update on bb2121 for relapsed myeloma
Ide-cel (formerly bb2121) anti-BCMA CAR T-cell therapy in relapsed/refractory MM
bb2121: bringing CAR T-cells into the multiple myeloma world
With bb2121, Is CAR T-Cell Therapy Ready for Myeloma?
From bb2121 to bb21217: does bb007 improve efficacy in MM?
The Latest Myeloma Research Updates from the EHA 2018 Meeting
Dr. Raje Discusses the Tolerability of bb2121 in Myeloma
